FRAMINGHAM — Sanofi Genzyme is doubling ... With some 5,000 workers in Massachusetts, Sanofi Genzyme continues to be the state’s largest employer in the life sciences industry.

Framingham drug developer Sanofi’s new facility has received ... square-foot complex in Cambridge to consolidate much of its Massachusetts operations. That facility is expected to open in ...

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding subsidiary Genzyme.

Sanofi’s innovation hub, which employs 2,500 people, is based in Cambridge, Massachusetts. Swiftwater, Pennsylvania contains the company’s vaccine production sites, whilst Framingham ...

French pharmaceutical giant Sanofi has received a warning letter from the U.S. Food and Drug Administration following an inspection at its drug manufacturing facility in Framingham. Biggest Boston ...

The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant ... their Genzyme manufacturing plant in Framingham, Massachusetts. On Jan. 15, 2025, a warning ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

The French drugmaker said it would commit at least $20bn in the US through 2030, with the aim to increase R&D and manufacturing capabilities. Sanofi’s current sites in the US stand to benefit from ...